JP2011500575A5 - - Google Patents

Download PDF

Info

Publication number
JP2011500575A5
JP2011500575A5 JP2010528941A JP2010528941A JP2011500575A5 JP 2011500575 A5 JP2011500575 A5 JP 2011500575A5 JP 2010528941 A JP2010528941 A JP 2010528941A JP 2010528941 A JP2010528941 A JP 2010528941A JP 2011500575 A5 JP2011500575 A5 JP 2011500575A5
Authority
JP
Japan
Prior art keywords
methyl
hydrogen
fluoro
ethyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010528941A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011500575A (ja
JP5291716B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/078294 external-priority patent/WO2009048765A1/en
Publication of JP2011500575A publication Critical patent/JP2011500575A/ja
Publication of JP2011500575A5 publication Critical patent/JP2011500575A5/ja
Application granted granted Critical
Publication of JP5291716B2 publication Critical patent/JP5291716B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010528941A 2007-10-12 2008-09-30 5−ht7受容体拮抗薬 Expired - Fee Related JP5291716B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97946407P 2007-10-12 2007-10-12
US60/979,464 2007-10-12
PCT/US2008/078294 WO2009048765A1 (en) 2007-10-12 2008-09-30 5-ht7 receptor antagonists

Publications (3)

Publication Number Publication Date
JP2011500575A JP2011500575A (ja) 2011-01-06
JP2011500575A5 true JP2011500575A5 (OSRAM) 2011-11-10
JP5291716B2 JP5291716B2 (ja) 2013-09-18

Family

ID=40134870

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010528941A Expired - Fee Related JP5291716B2 (ja) 2007-10-12 2008-09-30 5−ht7受容体拮抗薬

Country Status (19)

Country Link
US (1) US7910588B2 (OSRAM)
EP (1) EP2201002B1 (OSRAM)
JP (1) JP5291716B2 (OSRAM)
KR (1) KR101161070B1 (OSRAM)
CN (1) CN101821257B (OSRAM)
AT (1) ATE548365T1 (OSRAM)
AU (1) AU2008311154B2 (OSRAM)
BR (1) BRPI0818450A2 (OSRAM)
CA (1) CA2699674C (OSRAM)
CY (1) CY1112709T1 (OSRAM)
DK (1) DK2201002T3 (OSRAM)
EA (1) EA016787B1 (OSRAM)
ES (1) ES2380756T3 (OSRAM)
HR (1) HRP20120257T1 (OSRAM)
MX (1) MX2010003986A (OSRAM)
PL (1) PL2201002T3 (OSRAM)
PT (1) PT2201002E (OSRAM)
SI (1) SI2201002T1 (OSRAM)
WO (1) WO2009048765A1 (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI396857B (zh) * 2009-12-30 2013-05-21 Etron Technology Inc 晶片測試電路
EP2766353B1 (en) 2011-10-11 2015-06-17 UCB Pharma, S.A. 2-oxo-piperidinyl derivatives
ES2804545T3 (es) 2013-03-11 2021-02-08 Univ Temple Nuevos moduladores de la actividad del receptor de 5-hidroxitriptamina 7 y su método de uso
TW201601632A (zh) * 2013-11-20 2016-01-16 杜邦股份有限公司 1-芳基-3-烷基吡唑殺蟲劑
US10544117B2 (en) 2014-09-10 2020-01-28 Temple University—Of the Commonwealth System of Higher Education 5-hydroxytryptamine receptor 7 activity modulators and their method of use
IL309982A (en) 2016-11-15 2024-03-01 Univ Temple New modulators of 5-hydroxytryptamine receptor 7 and a method of using them
US11220505B2 (en) 2017-03-21 2022-01-11 Temple University-Of The Commonwealth System Of Higher Education 5-hydroxytryptamine receptor 7 modulators and their use as therapeutic agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465467B1 (en) * 1999-05-21 2002-10-15 Biovitrum Ab Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
US20030008880A1 (en) 2001-05-02 2003-01-09 Pfizer Inc. 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity
MXPA05008137A (es) * 2003-01-31 2005-09-30 Pfizer Prod Inc Antagonistas y agonistas de 5ht7.
US7211783B2 (en) 2004-01-09 2007-05-01 Tamperproof Container Licensing Corp. Tamper-proof container
JP2008501031A (ja) 2004-05-28 2008-01-17 バーテックス ファーマシューティカルズ インコーポレイテッド ムスカリン受容体のモジュレーター
TW200914020A (en) * 2007-08-28 2009-04-01 Lilly Co Eli Substituted piperazinyl pyrazines and pyridines as 5-HT7 receptor antagonists

Similar Documents

Publication Publication Date Title
JP2011519854A5 (OSRAM)
JP2013537203A5 (OSRAM)
JP2011500575A5 (OSRAM)
JP2013505969A5 (OSRAM)
JP2014511892A5 (OSRAM)
TR201904655T4 (tr) Piridilaminoasetik asit bileşiği.
JP2014525420A5 (OSRAM)
JP2011529054A5 (OSRAM)
JP2010536766A5 (OSRAM)
JP2012530765A5 (OSRAM)
JP2013507423A5 (OSRAM)
JP2010501478A5 (OSRAM)
JP2008513467A5 (OSRAM)
JP2017533968A5 (OSRAM)
JP2013510125A5 (OSRAM)
PH12012500752A1 (en) Benzimidazole-imidazole derivatives
MX2010003156A (es) Derivados de aril amida substituida con tetrazol y usos de los mismos.
JP2013528204A5 (OSRAM)
JP2014521625A5 (OSRAM)
JP2013544860A5 (OSRAM)
JP2012507535A5 (OSRAM)
JP2014504646A5 (OSRAM)
CN110891950A (zh) 一种三嗪化合物及其药学上可接受的盐
NO20092058L (no) Heteroaryl pyrrolidinyl ketonderivater
JP2013542980A5 (OSRAM)